KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Inventory (2021 - 2025)

Historic Change in Inventory for Novavax (NVAX) over the last 5 years, with Q3 2025 value amounting to $3.8 million.

  • Novavax's Change in Inventory rose 24976.7% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 12632.15%. This contributed to the annual value of -$12.9 million for FY2024, which is 11734.42% down from last year.
  • Novavax's Change in Inventory amounted to $3.8 million in Q3 2025, which was up 24976.7% from $4.0 million recorded in Q2 2025.
  • Novavax's Change in Inventory's 5-year high stood at $304.2 million during Q2 2022, with a 5-year trough of -$16.8 million in Q1 2024.
  • For the 5-year period, Novavax's Change in Inventory averaged around $34.6 million, with its median value being $6.4 million (2021).
  • In the last 5 years, Novavax's Change in Inventory soared by 47861.81% in 2022 and then plummeted by 28237.91% in 2024.
  • Over the past 5 years, Novavax's Change in Inventory (Quarter) stood at $8.9 million in 2021, then skyrocketed by 478.62% to $51.3 million in 2022, then tumbled by 115.75% to -$8.1 million in 2023, then surged by 102.34% to $189000.0 in 2024, then soared by 1885.71% to $3.8 million in 2025.
  • Its Change in Inventory was $3.8 million in Q3 2025, compared to $4.0 million in Q2 2025 and -$2.4 million in Q1 2025.